9 nominees · 3 ballot items.
Elect nine directors; approve, on an advisory basis, executive compensation (“Say on Pay”); and ratify Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.
Elect nine nominees to the Board of Directors to serve until the next annual meeting or until their successors are qualified.
Non-binding, advisory approval of the compensation paid to the Company’s Named Executive Officers as disclosed in the proxy statement.
Artivion’s advisory Say-on-Pay proposal requests non-binding shareholder approval of the compensation paid to its Named Executive Officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. Management seeks this annual approval to gauge investor support for its pay programs and to demonstrate accountability; the Compensation Committee uses market benchmarking, performance metrics (constant currency revenue growth and constant currency adjusted EBITDA), and independent consultant advice to design a pay-for-performance mix heavy on long-term equity incentives (RSUs and PSUs) with performance-based annual cash bonuses. The board recommends a FOR vote, noting that in 2025 the incentive metrics were achieved at 118.7% payout, reflecting alignment between pay and company performance, and emphasizing retention, market-competitive positioning, and long-term value creation. Key governance context includes robust stock ownership guidelines, a clawback policy, and independent compensation committee oversight; risks include concentrated pay at the CEO level and reliance on adjusted non-GAAP measures for payouts. The vote is advisory and does not bind the company, but the board will consider shareholder feedback in future compensation decisions.
Ratify the Audit Committee’s preliminary approval of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9.76% | 4,738,840 | $174M |
| 2 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 5.06% | 2,456,146 | $90M |
| 3 | FMR LLC | 5.04% | 2,447,959 | $90M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.02% | 1,952,008 | $71M |
| 5 | MORGAN STANLEY | 3.81% | 1,847,557 | $68M |
| 6 | STATE STREET CORP | 3.47% | 1,682,273 | $62M |
| 7 | PERCEPTIVE ADVISORS LLC | 3.37% | 1,637,290 | $60M |
| 8 | BlackRock, Inc. | 2.56% | 1,243,635 | $46M |
| 9 | Juniper Investment Company, LLC | 2.45% | 1,189,136 | $44M |
| 10 | Conestoga Capital Advisors, LLC | 2.42% | 1,175,410 | $43M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.